4.7 Review

Insulin-resistance and benign prostatic hyperplasia: The connection

Journal

EUROPEAN JOURNAL OF PHARMACOLOGY
Volume 641, Issue 2-3, Pages 75-81

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.ejphar.2010.05.042

Keywords

Insulin-resistance; Hyperinsulinemia; Prostate; Obesity; Diabetes; BPH; Hyperplasia

Funding

  1. National Institute of Pharmaceutical Education and Research (NIPER), S.A.S. Nagar, Mohali, Punjab, India

Ask authors/readers for more resources

Benign prostatic hyperplasia (BPH) is a highly prevalent disease in the aged men population characterized by augmented cell proliferation and contractility of the prostate gland. Prior studies have demonstrated the relationship between BPH and insulin-resistance syndrome. During insulin-resistance, hyperinsulinemia develops to combat the decreased responsiveness of the body towards insulin. Although, the compensatory hyperinsulinemia prevents development of fasting hyperglycemia in insulin-resistant individuals, the increased level of circulating insulin directly and/or indirectly affects different molecular signaling and can promote prostatic growth. Insulin-resistance syndrome includes group of disorders, such as obesity, dyslipidemia, sympathetic overactivity, hyperinsulinemia and each individually reported as risk factor for the development of BPH. The present review describes the inter-relationships between different insulinresistance associated factors and their possible involvement in the pathogenesis of BPH. (C) 2010 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available